GB0919893D0 - Drug composition and its use in therapy - Google Patents

Drug composition and its use in therapy

Info

Publication number
GB0919893D0
GB0919893D0 GBGB0919893.8A GB0919893A GB0919893D0 GB 0919893 D0 GB0919893 D0 GB 0919893D0 GB 0919893 A GB0919893 A GB 0919893A GB 0919893 D0 GB0919893 D0 GB 0919893D0
Authority
GB
United Kingdom
Prior art keywords
therapy
drug composition
drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0919893.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0919893.8A priority Critical patent/GB0919893D0/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of GB0919893D0 publication Critical patent/GB0919893D0/en
Priority to AU2010317668A priority patent/AU2010317668C1/en
Priority to CN201080051628.4A priority patent/CN102740853B/zh
Priority to RU2012124063/15A priority patent/RU2587329C2/ru
Priority to CA2780704A priority patent/CA2780704C/en
Priority to BR112012011224A priority patent/BR112012011224A2/pt
Priority to SG10201407496SA priority patent/SG10201407496SA/en
Priority to NZ599957A priority patent/NZ599957A/en
Priority to PE2012000650A priority patent/PE20121472A1/es
Priority to PCT/GB2010/051896 priority patent/WO2011058374A1/en
Priority to EP10778715A priority patent/EP2498776A1/en
Priority to JP2012538416A priority patent/JP2013510842A/ja
Priority to UAA201207163A priority patent/UA105940C2/ru
Priority to MX2012005538A priority patent/MX2012005538A/es
Priority to US13/446,217 priority patent/US20120252824A1/en
Priority to ECSP12011892 priority patent/ECSP12011892A/es
Priority to ECSP12011893 priority patent/ECSP12011893A/es
Priority to CO12078022A priority patent/CO6551745A2/es
Priority to IL219769A priority patent/IL219769A0/en
Priority to ZA2012/04247A priority patent/ZA201204247B/en
Priority to US14/287,015 priority patent/US9308211B2/en
Priority to US14/287,014 priority patent/US9314465B2/en
Priority to US14/488,215 priority patent/US20150005325A1/en
Priority to US14/687,393 priority patent/US20150216869A1/en
Priority to JP2015237086A priority patent/JP2016041748A/ja
Priority to US14/991,892 priority patent/US20160120899A1/en
Priority to US15/061,656 priority patent/US9700561B2/en
Priority to US15/063,465 priority patent/US9675618B2/en
Priority to US15/144,798 priority patent/US20160271136A1/en
Priority to US15/144,800 priority patent/US20160271197A1/en
Priority to US16/042,670 priority patent/US10420812B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0919893.8A 2009-06-16 2009-11-13 Drug composition and its use in therapy Ceased GB0919893D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
MX2012005538A MX2012005538A (es) 2009-11-13 2010-11-12 Combinacion de farmacos con teobromina y su uso en terapia.
SG10201407496SA SG10201407496SA (en) 2009-11-13 2010-11-12 Drug Combination With Theobromine And Its Use In Therapy
PE2012000650A PE20121472A1 (es) 2009-11-13 2010-11-12 Combinacion de farmacos con teobromina y su uso en terapia
RU2012124063/15A RU2587329C2 (ru) 2009-11-13 2010-11-12 Лекарственная комбинация с теобромином и ее использование в лечении
CA2780704A CA2780704C (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
BR112012011224A BR112012011224A2 (pt) 2009-11-13 2010-11-12 teobromina e agente combinado com um opióide antitussígeno e seu uso terapêutico
AU2010317668A AU2010317668C1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
NZ599957A NZ599957A (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
CN201080051628.4A CN102740853B (zh) 2009-11-13 2010-11-12 可可碱的药物组合及其在治疗中的用途
PCT/GB2010/051896 WO2011058374A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
EP10778715A EP2498776A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
JP2012538416A JP2013510842A (ja) 2009-11-13 2010-11-12 テオブロミンとの薬物組み合わせおよび治療におけるその使用
UAA201207163A UA105940C2 (ru) 2009-11-13 2010-11-12 Лекарственное комбинированное средство, соджержащее теобромин и опиат, для лечения кашля
US13/446,217 US20120252824A1 (en) 2009-06-16 2012-04-13 Drug Combinations and Uses in Treating a Coughing Condition
ECSP12011892 ECSP12011892A (es) 2009-11-13 2012-05-11 Combinación de fármacos con teobromina y su uso en terapia
ECSP12011893 ECSP12011893A (es) 2009-11-13 2012-05-11 Combinación de fármacos con teobromina y su uso en terapia
CO12078022A CO6551745A2 (es) 2009-11-13 2012-05-11 Combinación de fármacos con teobromina y su uso en terapia
IL219769A IL219769A0 (en) 2009-11-13 2012-05-13 Drug combination with theromine and its use in therapy
ZA2012/04247A ZA201204247B (en) 2009-11-13 2012-06-11 Drug combination with theobromine and its use in therapy
US14/287,015 US9308211B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,014 US9314465B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/488,215 US20150005325A1 (en) 2009-06-16 2014-09-16 Drug Combinations and Uses in Treating a Coughing Condition
US14/687,393 US20150216869A1 (en) 2009-06-16 2015-04-15 Drug Combinations and Uses in Treating a Coughing Condition
JP2015237086A JP2016041748A (ja) 2009-11-13 2015-12-04 テオブロミンとの薬物組み合わせおよび治療におけるその使用
US14/991,892 US20160120899A1 (en) 2009-06-16 2016-01-08 Drug Combinations and Uses in Treating a Coughing Condition
US15/061,656 US9700561B2 (en) 2009-06-16 2016-03-04 Drug combinations and uses in treating a coughing condition
US15/063,465 US9675618B2 (en) 2009-06-16 2016-03-07 Drug combinations and uses in treating a coughing condition
US15/144,798 US20160271136A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US15/144,800 US20160271197A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US16/042,670 US10420812B2 (en) 2009-06-16 2018-07-23 Drug combinations and uses in treating a coughing condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919893.8A GB0919893D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
GB0919893D0 true GB0919893D0 (en) 2009-12-30

Family

ID=41509327

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0919893.8A Ceased GB0919893D0 (en) 2009-06-16 2009-11-13 Drug composition and its use in therapy

Country Status (18)

Country Link
EP (1) EP2498776A1 (ru)
JP (2) JP2013510842A (ru)
CN (1) CN102740853B (ru)
AU (1) AU2010317668C1 (ru)
BR (1) BR112012011224A2 (ru)
CA (1) CA2780704C (ru)
CO (1) CO6551745A2 (ru)
EC (2) ECSP12011892A (ru)
GB (1) GB0919893D0 (ru)
IL (1) IL219769A0 (ru)
MX (1) MX2012005538A (ru)
NZ (1) NZ599957A (ru)
PE (1) PE20121472A1 (ru)
RU (1) RU2587329C2 (ru)
SG (1) SG10201407496SA (ru)
UA (1) UA105940C2 (ru)
WO (1) WO2011058374A1 (ru)
ZA (1) ZA201204247B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108064T1 (de) * 1987-10-08 1994-07-15 Andor Bilas Stoffgemisch zur stabilisierung der stoffwechsel- lage.
BR9407414A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6608073B1 (en) * 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US8080554B2 (en) * 2001-12-12 2011-12-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
EP1603533B1 (en) * 2003-02-28 2009-04-15 YM Biosciences Inc. Opioid delivery system
CN1593451A (zh) * 2003-09-12 2005-03-16 杨喜鸿 促进男性勃起的外用药物
WO2006064780A1 (ja) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. 便秘治療剤
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물

Also Published As

Publication number Publication date
CN102740853A (zh) 2012-10-17
CO6551745A2 (es) 2012-10-31
RU2012124063A (ru) 2013-12-20
JP2013510842A (ja) 2013-03-28
BR112012011224A2 (pt) 2017-03-01
CN102740853B (zh) 2015-04-08
WO2011058374A1 (en) 2011-05-19
ZA201204247B (en) 2013-02-27
AU2010317668C1 (en) 2016-02-11
MX2012005538A (es) 2012-09-28
ECSP12011893A (es) 2012-10-30
IL219769A0 (en) 2012-07-31
CA2780704A1 (en) 2011-05-19
CA2780704C (en) 2018-07-17
SG10201407496SA (en) 2015-02-27
NZ599957A (en) 2014-05-30
ECSP12011892A (es) 2012-09-28
AU2010317668A1 (en) 2012-06-07
UA105940C2 (ru) 2014-07-10
PE20121472A1 (es) 2012-11-30
AU2010317668B2 (en) 2015-01-22
JP2016041748A (ja) 2016-03-31
EP2498776A1 (en) 2012-09-19
RU2587329C2 (ru) 2016-06-20

Similar Documents

Publication Publication Date Title
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL218169A (en) Quinazoline compounds and their pharmaceutical compositions containing them for use in therapy
GB0817207D0 (en) therapeutic apsac compounds and their use
IL214244A0 (en) Scriptaid isosteres and their use in therapy
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB0921803D0 (en) Drug composition and its use in therapy
HK1168283A1 (zh) 類的試劑在治療抗胰島素和相關疾病的用途
IL219768A0 (en) Drug combination with thebromine and its use in therapy
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB2460180B (en) Depsipeptides and their therapeutic use
GB0909354D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy
GB0920267D0 (en) Drug combination and its use in therapy
GB201021425D0 (en) Drug composition and its use in therapy
GB201019971D0 (en) Drug composition and its use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)